Interstitial lung diseases: clinical features and management.
Interstitial lung diseases (ILDs) or diffuse parenchymal lung diseases are terms used to describe around 200 acute and chronic lung disorders (Raghu and Brown, 2004). They are a heterogeneous group of disorders of the lower respiratory tract that are characterised by both acute and chronic inflammation and a generally irreversible and relentless process of fibrosis in the interstitium and the alveolar walls (air sacs in the lungs) (Riches et al, 2003).
Ellis
Ross
R
Interstitial Lung Disease, Royal Brompton Hospital, London.
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D018893:Bronchoalveolar Lavage; D015984:Causality; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005080:Exercise Test; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000145:classification / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D016040:Lung Transplantation; D024802:Nurse's Role; D013902:Radiography, Thoracic; D012129:Respiratory Function Tests; D013727:Terminal Care
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents